In search of an ideal template for therapeutic genome editing: A review of current developments for structure optimization

por Shakirova, Alena, Karpov, Timofey, Komarova, Yaroslava, Lepik, Kirill
Publicado 2023

P062: The efficacy and safety of nivolumab 40 mg therapy versus 3 mg/kg in patients with relapsed and refractory classic Hodgkin lymphoma

por Fedorova, Liudmila, Lepik, Kirill, Mikhailova, Natalia, Kondakova, Elena, Komarova, Yaroslava, Kotselyabina, Polina, Borzenkova, Evgenia, Baykov, Vadim, Moiseev, Ivan, Kulagin, Alexander
Publicado 2022

P060: Prognosis of patients with relapsed and refractory classic Hodgkin lymphoma after nivolumab discontinuation and efficacy of nivolumab retreatment

por Fedorova, Liudmila, Lepik, Kirill, Mikhailova, Natalia, Kondakova, Elena, Komarova, Yaroslava, Kotselyabina, Polina, Borzenkova, Evgenia, Baykov, Vadim, Moiseev, Ivan, Kulagin, Alexander
Publicado 2022